Antimicrobial activity and pharmacokinetics/pharmacodynamics of the novel glycylcycline, tigecycline

被引：15

作者：

Peterson, LR ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Pathol & Lab Med, Clin Microbiol Div, Evanston, IL 60201 USA

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2005年 / 52卷 / 03期

关键词：

D O I：

10.1016/j.diagmicrobio.2005.06.011

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：163 / 164

页数：2

共 11 条

[1] In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004) [J].

Bouchillon, SK ;

Hoban, DJ ;

Johnson, BM ;

Johnson, JL ;

Hsiung, A ;

Dowzicky, MJ .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) :173-179

[2] Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004) [J].

Fritsche, TR ;

Sader, HS ;

Stilwell, MG ;

Dowzicky, MJ ;

Jones, RN .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) :195-201

[3] Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates [J].

Fritsche, TR ;

Strabala, PA ;

Sader, HS ;

Dowzicky, MJ ;

Jones, RN .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) :209-213

[4] Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia [J].

Fritsche, TR ;

Sader, HS ;

Stilwell, MG ;

Dowzicky, MJ ;

Jones, RN .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) :187-193

[5]

HOBAN DJ, 2004, DIAGN MICROBIOL INFE, V52, P215

[6] Pharmacokinetic/pharmacodynamic profile for tigecycline - a new glycylcycline antimicrobial agent [J].

Meagher, AK ;

Ambrose, PG ;

Grasela, TH ;

Ellis-Grosse, EJ .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) :165-171

[7] The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital [J].

Pop-Vicas, AE ;

D'Agata, EMC .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (12) :1792-1798

[8] Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit [J].

Sader, HS ;

Jones, RN ;

Dowzicky, MJ ;

Fritsche, TR .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) :203-208

[9] Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents [J].

Sader, HS ;

Jones, RN ;

Stilwell, MG ;

Dowzicky, MJ ;

Fritsche, TR .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) :181-186

[10]

STEVENS T, 2004, 44 INT C ANT AG CHEM

← 1 2 →